Multimorbidity across multiple ICD-10 codes should be considered when treating migraine patients
In migraine, co-occurrence of two or more diseases or conditions is typical. Asthma and allergies,...
In migraine, co-occurrence of two or more diseases or conditions is typical. Asthma and allergies,...
A new real world evidence study on Idiopathic pulmonary fibrosis (IPF) describes the high disease...
Chronic obstructive pulmonary disease is one of the leading causes of mortality and morbidity worldwide....
Healthcare provides various types of Real World Data (RWD) that can be used to generate...
The Burden of Migraine Study continues The study ‘Migraine comorbidity and phenotypic disease networks in...
Medaffcon’s new real-world evidence study on the burden of adult asthma in Finland demonstrates the...
HIMSS & Health 2.0 European conference took place on 11-13.6.2019 in Helsinki. 3 000 professionals...
The high mortality rate of heart failure (HF) patients compared to age-matched controls highlights the...
New real-world evidence (RWE) based study shows that migraine nearly doubles the amount of healthcare...
Pricing and reimbursement in Finland Pharmaceuticals Pricing Board (PPB), operating under the Ministry of Social...
Medaffcon pioneering biobank and real-world evidence research efforts in Finland The newest Biobanking in Finland...
BC Platforms AG, a world leader in genomic data management and analytics, today announces that...
Recently established Finnish hospital biobanks have launched new research activity in Finland. Through the Finnish biobank...
Public health authorities and pharmaceutical companies have searched for alternative funding formulas to share the...
Analyzing electronic health record (EHR) data has already provided us with new insights in medical...
Medaffcon has in collaboration with the University of Eastern Finland assessed the operational status of...
Demonstrating that a health technology, e.g. a product, procedure or any intervention, is worth its...
Medaffcon has created a unique platform that collects information about innovative Finnish efforts and technologies...
Currently huge piles of health care data have been collected in Finland through national, regional...
Risk-sharing agreements (RSA) are one of the most interesting and debated topics in the Finnish...
Learn about conditional reimbursement from the interview with CEO Jarmo Hahl, Medaffcon Oy. There’s often...
A top-level ecosystem emerging in Finland Medaffcon is currently mapping the most advanced practices in...
Medaffcon is known in Finland as the forerunner of commercial biobank studies. Strong cooperation network...
BACKGROUND Cancer precision medicine is currently raising considerable interest in healthcare. Healthcare is getting closer...
Like already mentioned in my previous post it is known that different Risk-Sharing Models have...
As we all know different Risk-Sharing Models (RSM) have been varyingly in use in different...
Pharma Industry Finland commissioned a report from Medaffcon concerning how effectiveness could be assessed in...
In our customer event in April, we examined risk-sharing models from three different perspectives. Director...
In the Medaffcon customer evening organised in April 2017, we went through data sources related...
The corporate acquisition opens up new opportunities for the utilisation of medical information in the...
At Medaffcon, we have invested in young professionals’ career development for years. By employing trainees,...
The assessment of treatment effectiveness should hold a central role in healthcare, in order to...
Medaffcon’s growth has not slowed down in January. In the beginning of the month both...
Tanja joined Medaffcon’s Market Access team in November 2016 Tanja gained her most recent work...
Tatu Sainio joined Medaffcon’s Market Access team in November 2016 Tatu has worked at Medaffcon...
Carina joined Medaffcon’s Medical Affairs team in September 2016 Carina holds a Doctor of Philosophy...
Mariann Lassenius joined Medaffcon’s Medical Affairs team in June 2016. Right before her transition to...
Cost-Awareness in Health Care Rising costs have forced the health care sector to reorganise itself....
Mariann joined Medaffcon’s Medical Affairs team in June 2016 Mariann completed her Master of Science...
Summary of Professor Samuli Ripatti’s presentation “Personalised medicine – where are we now and in...
Medaffcon welcomes back its first ever recruitment! In 2011 Simo Jääskeläinen was Medaffcon’s first recruitment....
I started working as an Expert Physician in the pharmaceutical industry approximately 15 years ago....
The precondition for a medicinal product to receive a marketing authorisation is that the product...
Paljon kysymyksiä, useita eri lähestymiskulmia ”Miten saada innovatiiviset lääkkeet ja lääkinnälliset laitteet nopeasti markkinoille ja...
Summary of Professor Martti Kekomäki’s Lecture on 6th April 2016 Social Welfare and Health Care...